Comparative Study on the Immunogenicity and Efficacy of Different Post-exposure Intramuscular Rabies Vaccination Regimens in China

被引:0
|
作者
SONG Yun [1 ]
HE Ying [2 ]
LU Xue Xin [2 ]
ZHANG Xiao Mei [3 ]
JIANG XIAO Lin [3 ]
SONG Qing [4 ]
HUANG Xue Yong [1 ]
MA Hong Xia [1 ]
YU Peng Cheng [2 ]
ZHU Wu Yang [2 ]
机构
[1] Henan Provincial Center for Disease Control and Prevention,Infectious Disease Prevention and Control Institute,Henan Provincial Key Laboratory of Infectious Disease Pathogens
[2] National Institute for Viral Disease Control and Prevention,China CDC,Key Laboratory of Biosafety,National Health Commission
[3] Shandong Provincial Center for Disease Control and Prevention
[4] Qingdao Chengyang District Center for Disease Control and Prevention
关键词
D O I
暂无
中图分类号
R186 [预防接种、计划免疫、药物预防];
学科分类号
100401 ;
摘要
Objective This study aimed to compare the current Essen rabies post-exposure immunization schedule(0-3-7-14-28) in China and the simple 4-dose schedule(0-3-7-14) newly recommended by the World Health Organization in terms of their safety, efficacy, and protection.Methods Mice were vaccinated according to different immunization schedules, and blood was collected for detection of rabies virus neutralizing antibodies(RVNAs) on days 14, 21, 28, 35, and 120after the first immunization. Additionally, different groups of mice were injected with lethal doses of the CVS-11 virus on day 0, subjected to different rabies immunization schedules, and assessed for morbidity and death status. In a clinical trial, 185 rabies-exposed individuals were selected for post-exposure vaccination according to the Essen schedule, and blood was collected for RVNAs detection on days 28and 42 after the first immunization.Results A statistically significant difference in RVNAs between mice in the Essen and 0-3-7-14 schedule groups was observed on the 35th day(P < 0.05). The groups 0-3-7-14, 0-3-7-21, and 0-3-7-28 showed no statistically significant difference(P > 0.05) in RVNAs levels at any time point. The post-exposure immune protective test showed that the survival rate of mice in the control group was 20%, whereas that in the immunization groups was 40%. In the clinical trial, the RVNAs positive conversion rates on days 28(14 days after 4 doses) and 42(14 days after 5 doses) were both 100%, and no significant difference in RVNAs levels was observed(P > 0.05).Conclusion The simple 4-dose schedule can produce sufficient RVNAs levels, with no significant effect of a delayed fourth vaccine dose(14–28 d) on the immunization potential.
引用
收藏
页码:178 / 186
页数:9
相关论文
共 50 条
  • [21] Adverse events following rabies post-exposure prophylaxis: A comparative study of two different schedules and two vaccines
    Sari, Tugba
    Tulek, Necla
    Bulut, Cemal
    Oral, Behic
    Ertem, Gunay Tuncer
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2014, 12 (06) : 659 - 666
  • [22] Evaluation of two intradermal vaccination regimens using purified chick embryo cell vaccine for post-exposure prophylaxis of rabies
    Madhusudana, SN
    Anand, NP
    Shamsundar, R
    NATIONAL MEDICAL JOURNAL OF INDIA, 2001, 14 (03): : 145 - 147
  • [23] Immunogenicity and efficacy of Fermi-type nerve tissue rabies vaccine in mice and in humans undergoing post-exposure prophylaxis for rabies in Ethiopia
    Ayele, W
    Fekadu, M
    Zewdie, B
    Beyene, M
    Bogle, Y
    Mocha, K
    Gebreegziabher, F
    ETHIOPIAN MEDICAL JOURNAL, 2001, 39 (04) : 313 - 321
  • [24] Ineffectiveness of rabies vaccination alone for post-exposure protection against rabies infection in animal models
    Zhang, Yi
    Zhang, Shoufeng
    Li, Lietao
    Hu, Rongliang
    Lin, Haixiang
    Liu, Hua
    Liu, Fang
    Shao, Hui
    Liu, Yuan
    ANTIVIRAL RESEARCH, 2016, 135 : 56 - 61
  • [25] Rabies post-exposure prophylaxis for a male with severe Henoch Schonlein purpura following rabies vaccination
    Zhu, Zheng-Gang
    Zheng, Yi
    Lu, Sha
    Hu, Quan
    Fang, Yuan
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (11) : 2666 - 2668
  • [26] Safety and immunogenicity of post exposure rabies vaccination in children with primary immunodeficiency
    Charoenlap, S.
    Chatchatee, P.
    Tantawichien, T.
    Udomchaisakul, P.
    Saengseesom, W.
    Hirankarn, N.
    Sodsai, P.
    Ngamphaiboon, J.
    Suratannon, N.
    ALLERGY, 2018, 73 : 454 - 454
  • [27] Immunogenicity and safety of four different dosing regimens of anthrax vaccine adsorbed for post-exposure prophylaxis for anthrax in adults
    Bernstein, David I.
    Jackson, Lisa
    Patel, Shital M.
    El Sahly, Hana M.
    Spearman, Paul
    Rouphael, Nadine
    Rudge, Thomas L., Jr.
    Hill, Heather
    Goll, Johannes B.
    VACCINE, 2014, 32 (47) : 6284 - 6293
  • [28] Simulated post-exposure rabies vaccination: comments on article by Madhusudana et al
    Wilde, H
    Khawplod, P
    Hemachudha, T
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2004, 8 (06) : 374 - 375
  • [29] Efficacy of rabies immunoglobulins in an experimental post-exposure prophylaxis rodent model
    Servat, A
    Lutsch, C
    Delore, V
    Lang, J
    Veitch, K
    Cliquet, F
    VACCINE, 2003, 22 (02) : 244 - 249
  • [30] COST DIFFERENCES BETWEEN COMPLETE AND INCOMPLETE POST-EXPOSURE COURSES OF RABIES VACCINATION
    Sittichanbuncha, Yuwares
    Chairat, Chalermpon
    Sawanyawisuth, Kittisak
    Senthong, Vichai
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2014, 45 (05) : 1048 - 1052